Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daptomycin vs Ceftriaxone in Community-Acquired Pneumonia
NCT00538694Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Oct 2000
- Primary completion
- Sep 2001
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
01
Overview
A Phase 3 trial of daptomycin in community acquired pneumonia (CAP), sponsored by Merck & Co.. Started Oct 2000; status: completed.
02
Drugs
daptomycin
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT00538694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00538694.